EU regulators also backed Trelegy
This week’s news
App significantly improves behaviour and attention in children with ADHD.
EU regulators recommend PARP inhibitor Zejula
Eighteen ‘fast follower’ NHS trusts will be paired with NHS Global Digital Exemplars.
Novo hopes data will justify higher price compared with rival.
Cardioprotective effect occurred in patients independently of blood sugar control
Funding will go toward expansion of platform capabilities.
Heart Rate app will feature in FDA and Stanford study.